The invasive potential of CRC cells was also reduced by SSO treatment (Fig. 6G, H), indicating that CD36 inhibition counters the enhanced proliferation and metastatic capacity induced by PLIN2 overexpression. Here, CD36 is linked to colorectal carcinoma.